№ lp_1_2_23274
File format: docx Character count: 51115 File size: 211 KB
The guideline provides a comprehensive framework for the diagnosis and management of balanoposthitis, focusing on infective causes, dermatological conditions, and systemic diseases, primarily for sexual health services in the UK.
Year: 2025
Region / City: United Kingdom
Theme: Genitourinary Medicine, Sexual Health
Document Type: Clinical Guideline
Organization: British Association for Sexual Health and HIV (BASHH)
Author: Sarah K Edwards, Pareswaran Shashidharan, Imali Fernanado, Georgina Morris, Dayan Vijeratnum, Jason Eng Kiat Lim, Deepa Grover
Target Audience: Healthcare professionals working in sexual health services
Period of Validity: Ongoing, with formal reviews every 5 years
Approval Date: August 2025
Date of Last Review: August 2020
Date of Last Update: August 2025
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Patient Group Direction for Supply of Clotrimazole 1% Cream for Symptomatic Relief of Vulvo-Vaginal Candidiasis or Candidal Balanoposthitis (Version 2.0, July 2023)
Document type: Patient Group Direction (PGD) template
Medication: Clotrimazole 1% cream
Clinical indication: Vulvo-vaginal candidiasis; candidal balanoposthitis
Version: 2.0
Date of version update: July 2023
Template effective date: November 2023
Review date: May 2026
Expiry date: October 2026
Developing group: Sexual Health PGDs Short Life Working Group
Approving organisation: British Association for Sexual Health and HIV (BASHH)
Relevant guidance source: NICE MPG2 Patient Group Directions 2017
Sector: Sexual health services
Intended users: Registered healthcare professionals authorised to operate under a PGD
Organisational context: NHS or Local Authority commissioned sexual health services
Professional roles involved: Pharmacists, doctors, nurses, midwives, sexual health specialists
Governance requirement: Authorisation by senior doctor, senior pharmacist and organisational representative
Associated organisations: Specialist Pharmacy Service; Royal College of Midwives; Royal College of Nursing; Faculty of Sexual and Reproductive Healthcare; Centre for Pharmacy Postgraduate Education; British Pregnancy Advisory Service
Geographical scope: United Kingdom
Magnetic Resonance Imaging to estimate Tissue deformations during penile clamp application: A case series
Year: 2026
Region / City: Southampton, UK; Tel Aviv, Israel; Bristol, UK
Subject: Urology; Medical Imaging; Post-Prostatectomy Care
Document Type: Peer-reviewed journal article (accepted draft)
Institution: University of Southampton, Tel Aviv University, University Hospital Southampton, University of Bristol
Authors: J. Lemmens, L. Peko Cohen, PR Worsley, C. Everitt, J. Broadbridge, A. Gefen, RW Rees, M. Drake, MC Macaulay, M. Fader, DL Bader
Corresponding Author: PR Worsley
Methodology: Case series using MRI to measure tissue deformation under penile clamp application
Study Population: Three males post-radical prostatectomy with urinary incontinence
Keywords: Penile Clamp; Magnetic Resonance Imaging; Radical Prostatectomy; Urinary Incontinence
Level of Evidence: 4
Ethics Approval: Faculty of Health Sciences reference: 23407
Device Types Tested: Dribblestop® and Wiesner clamps (MRI-compatible modifications)
Age Range of Participants: 69–78 years
BASHH position statement on doxycycline use in pregnancy
Year: 2024
Region / City: United Kingdom
Subject: Doxycycline use during pregnancy
Document type: Position statement
Organization / Institution: BASHH (British Association for Sexual Health and HIV)
Author: Ali Grant; on behalf of BASHH Clinical Effectiveness Group (CEG)
Target audience: Healthcare professionals
Effective period: Not specified
Approval date: Not specified
Date of changes: Not specified
BASHH Undergraduate Prizes Regulations
Year: 2025
Region / City: United Kingdom
Topic: Undergraduate Prizes in Medical and Clinical Research
Document Type: Regulations
Organization / Institution: BASHH (British Association for Sexual Health and HIV)
Author: BASHH Education Committee
Target Audience: Undergraduate students in medicine or related fields
Start Date: Not specified
End Date: Not specified
Approval Date: Not specified
Amendment Date: March 2025
BASHH CEG conflict of interest declaration
Year: 2026
Region / City: Not specified
Topic: Conflict of interest in clinical guideline development
Document Type: Declaration
Organization / Institution: BASHH (British Association for Sexual Health and HIV)
Author: BASHH Clinical Effectiveness Group (CEG)
Target Audience: Members of the BASHH CEG and guideline authors
Validity Period: Not specified
Approval Date: Not specified
Date of Changes: Not specified
Topics: Balanoposthitis penile BASHH